Top 8 Companies in the Wound Care Market

The global wound care market was valued at USD 22.05 billion in 2023, driven by the increasing prevalence of chronic wounds across the globe. The market size is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032 to achieve a value of USD 34.21 billion by 2032.

Wound care products are used to promote the healing of wounds caused by accidents, surgeries, venous ulcers, foot ulcers, stress ulcers, and others. The market for wound care products is poised to witness significant growth due to the rising geriatric population and chronic diseases such as diabetes among others. The rising prevalence of diabetes is responsible for the increasing occurrence of several ulcers among diabetic people. The escalating demand for advanced wound care solutions and awareness of effective wound care among healthcare providers is projected to augment the market growth.

The market is also experiencing increasing technological advancements in the advanced wound care sector, enabling enhanced patient outcomes, and propelling market growth. For instance, in January 2024, Coloplast, a Danish multinational healthcare company, launched Biatain Silicone Fit with 3DFit Technology. It is a wound care solution suitable for both pressure injury prevention and wound management. The product launch is poised to expand its footprint within the foam dressing domain. The chronic wounds burden is allegedly affecting 10.5 million people in the United States. Globally, the number of people suffering from foot ulcers ranged between 9.1 and 26.1 million, and with a substantial increase the estimate is now 40-60 million people. This growth can be attributed to the increasing prevalence of diabetes.

Market players are focusing significantly on bringing new and effective wound-care solutions for people and healthcare providers. These new product launches are expected to contribute to the rise in the available number of treatments and wound care management solutions in the market, boosting market demand. For instance, in April 2023, Xtant Medical launched two amniotic membrane allografts, SimpliGraft and SimpliMax for wound management. The allografts are dehydrated, terminally irradiated, single- and dual-layer amniotic membrane sheets. The products protect by acting as a barrier and provide effective coverage from the surrounding environment when applied on the surface of both chronic and acute wounds. With the launch of these allografts, Xtant Medical has marked a significant milestone in the market expansion as it has stepped into the wound care market with this launch, positioning the company as a leader in the market.

Additionally, in September 2023, MiMedx Group launched EPIEFFECT, which is the latest product in the company’s advanced wound care solutions portfolio. The product caters to clinicians treating acute and chronic, hard-to-heal wounds such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs), among other common conditions. The EPIEFFECT provides a thick, tri-layer configuration that perfectly secures the graft in place with sutures. Moreover, the product provides promising and effective characteristics for treating deep or tunneling wounds, contributing to the increasing preference for such products and increasing adoption among healthcare providers.

Top Companies Leading the Wound Care Market in 2024

3M Company

Headquartered in Minnesota, and a global innovation powerhouse, 3M is renowned for its technological expertise across various industries. The company’s portfolio includes advanced wound dressings, negative pressure wound therapy (NPWT) systems, and surgical tapes. The company has renowned brands operational within hospitals and clinical settings worldwide such as Tegaderm and Coban.

Smith & Nephew plc

A British multinational medical equipment manufacturer, Smith & Nephew specialises in advanced wound management. Its wound care portfolio includes products for treating chronic wounds, burns, and surgical wounds, with brands like Allevyn, PICO, and IODOSORB playing a major role in modern wound care practices.

Integra LifeSciences Holdings Corporation

Integra is a leading medical technology company focused on regenerative technologies. The company offers products like collagen dressings, skin substitutes, and wound matrix technologies. These are particularly significant in treating severe burns, chronic wounds, and other difficult-to-heal injuries.

Mölnlycke Health Care AB

Based in Sweden, Mölnlycke is a global leader in wound care and surgical products. It offers advanced wound care solutions such as Mepilex foam dressings and Mepitel soft silicone dressings, aimed at managing chronic wounds, pressure ulcers, and burns while promoting faster healing and patient comfort.

ConvaTec Group plc.

ConvaTec is a UK-based company focused on advanced wound care solutions for chronic and complex wounds. Its product range includes foam dressings, hydrocolloid dressings, and negative pressure wound therapy (NPWT) systems, helping improve outcomes in wound healing, infection control, and patient comfort.

Coloplast A/S

A Danish multinational, Coloplast focuses on intimate healthcare products, with a strong wound care division. Its portfolio includes Biatain silicone foam dressings and antimicrobial wound care solutions, primarily catering to chronic wound management and infection prevention for patients with conditions like ulcers and post-surgical wounds.

Medtronic

Medtronic is a global healthcare solutions company known for its medical technologies. In the wound care market, its offerings focus on NPWT systems, particularly through its subsidiary, KCI. These therapies assist in treating chronic wounds, surgical wounds, and severe burns by accelerating healing through controlled pressure.

Johnson and Johnson Services, Inc.

A global leader in healthcare, Johnson & Johnson operates through its subsidiary, Ethicon, in the wound care market. Its portfolio includes sutures, surgical dressings, and infection management products designed to support both acute and chronic wound healing, with a strong emphasis on post-surgical care.